LB54640
LG-MCCL005
Phase 2 small_molecule completed
Quick answer
LB54640 for Hypothalamic Obesity is a Phase 2 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RHYTHM PHARMACEUTICALS, INC.
- Indication
- Hypothalamic Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed